Brigham and Women’s Hospital Heart & Vascular Center

Professor of Medicine, Harvard Medical School

Dr. Bhatt has received research funding from Abbott, Afimmune, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, CSL Behring, Eisai, Ethicon, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Idorsia, Irowood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis, Synaptic, and The Medicines Company, and the CME Program has determined there is no conflict of interest. Presentation will include discussion of unlabeled/investigational uses of a commercial product.